OverCOVID

OverCOVID integrates bioinformatics resources and molecular, phylogenetic, genomic, and interaction data on SARS-CoV-2 to support analyses of viral pathogenesis, target prioritization, and drug repurposing.

Key Features:

• Integration of Molecular Information: Aggregates tools and molecular data specific to SARS-CoV-2 to enable analyses of viral mechanisms and virus–host interactions.
• Phylogenetic Characteristics and Genomic Conservation: Provides phylogenetic information and genomic conservation data for tracking SARS-CoV-2 evolution and identifying conserved regions relevant to drug and target selection.
• Interaction Data: Includes virus–host interaction datasets that describe SARS-CoV-2 interactions with human cellular components implicated in entry, replication, and pathogenesis.
• Resource Compilation: Compiles databases and computational tools related to SARS-CoV-2, including repositories of genomic and interaction data.
• Drug Repurposing and Target Prioritization: Integrates diverse datasets to support prioritization of therapeutic targets and identification of candidate drugs for repurposing against SARS-CoV-2.

Scientific Applications:

• Viral Pathogenesis Analysis: Supports investigation of SARS-CoV-2 molecular mechanisms and virus–host interactions to elucidate pathogenesis.
• Therapeutic Target Discovery and Drug Repurposing: Enables computational studies for identifying and prioritizing antiviral targets and candidate repurposed drugs.
• Data Integration for Collaborative Research: Provides consolidated access to phylogenetic, genomic, and interaction datasets to support joint computational and experimental studies on SARS-CoV-2.

Methodology:

Systematic review and integration of existing SARS-CoV-2 knowledge, including phylogenetic analysis, genomic data aggregation, and incorporation of interaction studies.